Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowGuidant drama keeps building Stock sales by Dollens, others may stoke lawsuits. Analysts say firm will be OK if sale to Johnson & Johnson unravels.
Please enable JavaScript to view this content.